Literature DB >> 27105329

Differentiated Vulvar Intraepithelial Neoplasia: What Criteria Do We Use in Practice?

Jason C Reutter1, Ruth A Walters, M Angelica Selim.   

Abstract

OBJECTIVES: We sought to recognize the working diagnostic criteria for differentiated vulvar intraepithelial neoplasia (dVIN) among expert pathologists in the field. We also sought the frequency of definitive diagnosis, terminology of equivocal lesions, and views on dVIN's biological significance.
METHODS: Respondents ranked 26 histological and 8 ancillary studies and 5 clinical findings as "essential," "nonessential but strongly supports diagnosis," "possibly supports diagnosis," "weighs against diagnosis" or "uncertain significance or noncontributory." Consensus was defined as 75% agreement. They were asked about diagnosing dVIN on partially sampled lesions, terminology for uncertain lesions, frequency of diagnosis of dVIN relative to uncertain lesions, and if dVIN a is a precursor to an invasion.
RESULTS: Twenty-three completed the survey. Only "basal layer atypia" met consensus (86%) as essential. Consensus criteria for being at least strongly supportive of dVIN were "basal layer hyperchromasia," "presence of basal layer mitoses," and "large keratinocytes with abundant eosinophilic cytoplasm." Only "block-like positivity with p16" or positive HPV specific studies weighed against the diagnosis by consensus. Approximately 87% diagnosed dVIN on partially sampled lesions. Squamous cell hyperplasia with atypia was the most frequent terminology used for uncertain lesions; 87% felt dVIN is a precursor to invasion.
CONCLUSIONS: Only basal layer atypia was considered diagnostically essential by consensus. Additional criteria that strongly support the diagnosis include changes affecting the basal layer and abundant eosinophilic keratinocytic cytoplasm. There was no consensus on ancillary study findings to confirm dVIN. Most would diagnose dVIN on a partial sample. Most consider dVIN a precursor to invasion.

Entities:  

Mesh:

Year:  2016        PMID: 27105329     DOI: 10.1097/LGT.0000000000000211

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  6 in total

Review 1.  New Directions in Vulvar Cancer Pathology.

Authors:  Anthony Williams; Sheeba Syed; Shireen Velangi; Raji Ganesan
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

2.  HPV-negative Penile Intraepithelial Neoplasia (PeIN) With Basaloid Features.

Authors:  José Guerrero; Isabel Trias; Luis Veloza; Marta Del Pino; Adriana Garcia; Lorena Marimon; Sherley Diaz-Mercedes; Maria T Rodrigo-Calvo; Silvia Alós; Tarek Ajami; Rafael Parra-Medina; Antonio Martinez; Oscar Reig; Maria J Ribal; Juan M Corral-Molina; Jaume Ordi; Inmaculada Ribera-Cortada; Natalia Rakislova
Journal:  Am J Surg Pathol       Date:  2022-03-17       Impact factor: 6.298

3.  Differentiated vulvar intraepithelial neoplasia (dVIN): the most helpful histological features and the utility of cytokeratins 13 and 17.

Authors:  Shatavisha Dasgupta; Patricia C Ewing-Graham; Folkert J van Kemenade; Helena C van Doorn; Vincent Noordhoek Hegt; Senada Koljenović
Journal:  Virchows Arch       Date:  2018-09-06       Impact factor: 4.064

Review 4.  The Vulvar Cancer Risk in Differentiated Vulvar Intraepithelial Neoplasia: A Systematic Review.

Authors:  Féline O Voss; Nikki B Thuijs; Ravi F M Vermeulen; Erica A Wilthagen; Marc van Beurden; Maaike C G Bleeker
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

5.  Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.

Authors:  Debra S Heller; Tania Day; Jill I Allbritton; James Scurry; Gianluigi Radici; Kathryn Welch; Mario Preti
Journal:  J Low Genit Tract Dis       Date:  2021-01-01       Impact factor: 3.842

6.  Histological interpretation of differentiated vulvar intraepithelial neoplasia (dVIN) remains challenging-observations from a bi-national ring-study.

Authors:  Elf de Jonge; Mieke R Van Bockstal; Luthy S M Wong-Alcala; Suzanne Wilhelmus; Lex A C F Makkus; Katrien Schelfout; Koen K Van de Vijver; Sander Smits; Etienne Marbaix; Shatavisha Dasgupta; Senada Koljenović; Folkert J van Kemenade; Patricia C Ewing-Graham
Journal:  Virchows Arch       Date:  2021-03-08       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.